share_log

Orchard Therapeutics Q2 EPS $(0.04) Up From $(0.29) YoY

Orchard Therapeutics Q2 EPS $(0.04) Up From $(0.29) YoY

果园治疗公司第二季度每股收益为0.04美元,高于去年同期的0.29美元
Benzinga Real-time News ·  2022/08/04 09:28

Orchard Therapeutics (NASDAQ:ORTX) reported quarterly losses of $(0.04) per share. This is a 86.21 percent increase over losses of $(0.29) per share from the same period last year.

果园治疗公司(纳斯达克代码:ORTX)公布季度亏损为每股0.04美元。这比去年同期每股亏损0.29美元增加了86.21%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发